{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:50:55Z","timestamp":1789159855059,"version":"build-2803163510"},"reference-count":39,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatitis A virus immunoglobulin M (HAV-IgM) is often used to diagnose acute hepatitis A virus (HAV) infection serologically. However, false-positive test results can interfere with the diagnosis. A 56-year-old woman was readmitted to the hospital owing to abnormal liver function tests for the last 18 months. She had been diagnosed with acute HAV and was hospitalized in isolation based on a positive HAV-IgM test 18 months ago. Regular follow-up after discharge showed abnormal liver function and an elevated level of antinuclear antibodies and immunoglobulin G. For the last 15 days, the patient had fatigue, decreased appetite, and yellow urine, signaling recrudescence. Liver function tests were also abnormal. Liver biopsy revealed histological changes consistent with typical autoimmune hepatitis. After 2 months of methylprednisolone treatment, liver function returned to normal, and HAV-IgM turned negative. The diagnosis of acute HAV in nonendemic areas requires a comprehensive analysis of epidemic history, clinical characteristics, etiology, etc.<\/jats:p>","DOI":"10.1515\/med-2021-0336","type":"journal-article","created":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T18:23:58Z","timestamp":1631039038000},"page":"1311-1317","source":"Crossref","is-referenced-by-count":10,"title":["Sustained false-positive results for hepatitis A virus immunoglobulin M: A case report and literature review"],"prefix":"10.1515","volume":"16","author":[{"given":"Youwen","family":"Tan","sequence":"first","affiliation":[{"name":"Department of Hepatology, The Third Hospital of Zhenjiang Affiliated Jiangsu University , No. 300, Daijiamen, Runzhou Distinct , Zhenjiang 212003 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hepatology, The Third Hospital of Zhenjiang Affiliated Jiangsu University , Zhenjiang 212003 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2021,9,7]]},"reference":[{"key":"2022091918191493589_j_med-2021-0336_ref_001","doi-asserted-by":"crossref","unstructured":"Lemon SM\n, \nOtt JJ\n, \nVan Damme P\n, \nShouval D\n. Type A viral hepatitis: a summary and update on the molecular virology, epidemiology, pathogenesis and prevention. J Hepatol. 2017 Sep 5;68:167\u201384.","DOI":"10.1016\/j.jhep.2017.08.034"},{"key":"2022091918191493589_j_med-2021-0336_ref_002","doi-asserted-by":"crossref","unstructured":"Bower WA\n, \nNainan OV\n, \nHan X\n, \nMargolis HS\n. Duration of viremia in hepatitis A virus infection. J Infect Dis. 2000 Jul;182(1):12\u20137.","DOI":"10.1086\/315701"},{"key":"2022091918191493589_j_med-2021-0336_ref_003","doi-asserted-by":"crossref","unstructured":"Cohen JI\n, \nFeinstone S\n, \nPurcell RH\n. Hepatitis A virus infection in a chimpanzee: duration of viremia and detection of virus in saliva and throat swabs. J Infect Dis. 1989 Nov;160(5):887\u201390.","DOI":"10.1093\/infdis\/160.5.887"},{"key":"2022091918191493589_j_med-2021-0336_ref_004","doi-asserted-by":"crossref","unstructured":"Lemon SM\n. Type A viral hepatitis: epidemiology, diagnosis, and prevention. Clin Chem. 1997 Aug;43(8 Pt 2):1494\u20139.","DOI":"10.1093\/clinchem\/43.8.1494"},{"key":"2022091918191493589_j_med-2021-0336_ref_005","doi-asserted-by":"crossref","unstructured":"Cuthbert JA\n. Hepatitis A: old and new. Clin Microbiol Rev. 2001 Jan;14(1):38\u201358.","DOI":"10.1128\/CMR.14.1.38-58.2001"},{"key":"2022091918191493589_j_med-2021-0336_ref_006","unstructured":"Centers for Disease C, Prevention. Positive test results for acute hepatitis A virus infection among persons with no recent history of acute hepatitis \u2013 United States, 2002\u20132004. Morb Mortal Wkly Rep. 2005 May 13;54(18):453\u20136."},{"key":"2022091918191493589_j_med-2021-0336_ref_007","doi-asserted-by":"crossref","unstructured":"Sun X\n, \nWang F\n, \nZheng H\n, \nMiao N\n, \nYuan Q\n, \nCui F\n, et al. The impact of expanded program on immunization with live attenuated and inactivated Hepatitis A vaccines in China, 2004\u20132016. Vaccine. 2018 Feb 28;36(10):1279\u201384.","DOI":"10.1016\/j.vaccine.2018.01.043"},{"key":"2022091918191493589_j_med-2021-0336_ref_008","doi-asserted-by":"crossref","unstructured":"Alatoom A\n, \nAnsari MQ\n, \nCuthbert J\n. Multiple factors contribute to positive results for hepatitis A virus immunoglobulin M antibody. Arch Pathol Lab Med. 2013 Jan;137(1):90\u20135.","DOI":"10.5858\/arpa.2011-0693-OA"},{"key":"2022091918191493589_j_med-2021-0336_ref_009","doi-asserted-by":"crossref","unstructured":"Nainan OV\n, \nXia G\n, \nVaughan G\n, \nMargolis HS\n. Diagnosis of hepatitis a virus infection: a molecular approach. Clin Microbiol Rev. 2006 Jan;19(1):63\u201379.","DOI":"10.1128\/CMR.19.1.63-79.2006"},{"key":"2022091918191493589_j_med-2021-0336_ref_010","doi-asserted-by":"crossref","unstructured":"Desai AN\n, \nKim AY\n. Management of hepatitis A in 2020\u20132021. JAMA. 2020 Jul 28;324(4):383\u201384.","DOI":"10.1001\/jama.2020.4017"},{"key":"2022091918191493589_j_med-2021-0336_ref_011","doi-asserted-by":"crossref","unstructured":"Woods CR\n. False-positive results for immunoglobulin M serologic results: explanations and examples. J Pediatric Infect Dis Soc. 2013 Mar;2(1):87\u201390.","DOI":"10.1093\/jpids\/pis133"},{"key":"2022091918191493589_j_med-2021-0336_ref_012","doi-asserted-by":"crossref","unstructured":"Sakiani S\n, \nKoh C\n, \nHeller T\n. Understanding the presence of false-positive antibodies in acute hepatitis. J Infect Dis. 2014 Dec 15;210(12):1886\u20139.","DOI":"10.1093\/infdis\/jiu348"},{"key":"2022091918191493589_j_med-2021-0336_ref_013","doi-asserted-by":"crossref","unstructured":"Mac Kenzie WR\n, \nDavis JP\n, \nPeterson DE\n, \nHibbard AJ\n, \nBecker G\n, \nZarvan BS\n. Multiple false-positive serologic tests for HIV, HTLV-1, and hepatitis C following influenza vaccination, 1991. JAMA. 1992 Aug 26;268(8):1015\u20137.","DOI":"10.1001\/jama.268.8.1015"},{"key":"2022091918191493589_j_med-2021-0336_ref_014","doi-asserted-by":"crossref","unstructured":"Asnis DS\n, \nConetta R\n, \nTeixeira AA\n, \nWaldman G\n, \nSampson BA\n. The West Nile Virus outbreak of 1999 in New York: the Flushing Hospital experience. Clin Infect Dis. 2000 Mar;30(3):413\u20138.","DOI":"10.1086\/313737"},{"key":"2022091918191493589_j_med-2021-0336_ref_015","unstructured":"Centers for Disease C, Prevention. Human Jamestown canyon virus infection \u2013 Montana, 2009. Morb Mortal Wkly Rep. 2011 May 27;60(20):652\u20135."},{"key":"2022091918191493589_j_med-2021-0336_ref_016","doi-asserted-by":"crossref","unstructured":"Hyams C\n, \nMabayoje DA\n, \nCopping R\n, \nMaranao D\n, \nPatel M\n, \nLabbett W\n, et al. Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infection. J Med Virol. 2014 Mar;86(3):478\u201383.","DOI":"10.1002\/jmv.23827"},{"key":"2022091918191493589_j_med-2021-0336_ref_017","doi-asserted-by":"crossref","unstructured":"Tennant E\n, \nPost JJ\n. Production of false-positive immunoglobulin M antibodies to hepatitis A virus in autoimmune events. J Infect Dis. 2016 Jan 15;213(2):324\u20135.","DOI":"10.1093\/infdis\/jiv417"},{"key":"2022091918191493589_j_med-2021-0336_ref_018","doi-asserted-by":"crossref","unstructured":"Sohn MJ\n, \nCho JM\n, \nMoon JS\n, \nKo JS\n, \nYang HREBV\n. VCA IgM and cytomegalovirus IgM dual positivity is a false positive finding related to age and hepatic involvement of primary Epstein-Barr virus infection in children. Medicine (Baltimore). 2018 Sep;97(38):e12380.","DOI":"10.1097\/MD.0000000000012380"},{"key":"2022091918191493589_j_med-2021-0336_ref_019","doi-asserted-by":"crossref","unstructured":"Post JJ\n, \nChan MK\n, \nWhybin LR\n, \nShi Q\n, \nRawlinson WD\n, \nCunningham P\n, et al. Positive Epstein-Barr virus and cytomegalovirus IgM assays in primary HIV infection. J Med Virol. 2011 Aug;83(8):1406\u20139.","DOI":"10.1002\/jmv.22109"},{"key":"2022091918191493589_j_med-2021-0336_ref_020","doi-asserted-by":"crossref","unstructured":"Just-Nubling G\n, \nKorn S\n, \nLudwig B\n, \nStephan C\n, \nDoerr HW\n, \nPreiser W\n. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects. Infection. 2003 Oct;31(5):318\u201323.","DOI":"10.1007\/s15010-003-3129-y"},{"key":"2022091918191493589_j_med-2021-0336_ref_021","doi-asserted-by":"crossref","unstructured":"Aalto SM\n, \nLinnavuori K\n, \nPeltola H\n, \nVuori E\n, \nWeissbrich B\n, \nSchubert J\n, et al. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol. 1998 Nov;56(3):186\u201391.","DOI":"10.1002\/(SICI)1096-9071(199811)56:3<186::AID-JMV2>3.0.CO;2-3"},{"key":"2022091918191493589_j_med-2021-0336_ref_022","doi-asserted-by":"crossref","unstructured":"Meurman OH\n, \nZiola BR\n. IgM-class rheumatoid factor interference in the solid-phase radioimmunoassay of rubella-specific IgM antibodies. J Clin Pathol. 1978 May;31(5):483\u20137.","DOI":"10.1136\/jcp.31.5.483"},{"key":"2022091918191493589_j_med-2021-0336_ref_023","doi-asserted-by":"crossref","unstructured":"Bartels EM\n, \nRibel-Madsen S\n. Cytokine measurements and possible interference from heterophilic antibodies--problems and solutions experienced with rheumatoid factor. Methods. 2013 May 15;61(1):18\u201322.","DOI":"10.1016\/j.ymeth.2012.12.015"},{"key":"2022091918191493589_j_med-2021-0336_ref_024","doi-asserted-by":"crossref","unstructured":"Chen T\n, \nHedman L\n, \nMattila PS\n, \nJartti L\n, \nJartti T\n, \nRuuskanen O\n, et al. Biotin IgM antibodies in human blood: a previously unknown factor eliciting false results in biotinylation-based immunoassays. PLoS One. 2012;7(8):e42376.","DOI":"10.1371\/journal.pone.0042376"},{"key":"2022091918191493589_j_med-2021-0336_ref_025","doi-asserted-by":"crossref","unstructured":"Kamata A\n, \nObinata K\n, \nNiizuma T\n, \nKinoshita K\n, \nShimizu T\n. The validity of the criteria for primary infection of Chlamydophila pneumoniae in children by measuring ELISA IgM antibodies. J Infect Chemother. 2012 Jun;18(3):308\u201312.","DOI":"10.1007\/s10156-011-0327-x"},{"key":"2022091918191493589_j_med-2021-0336_ref_026","doi-asserted-by":"crossref","unstructured":"Prince HE\n, \nLieberman JM\n. Impact of the Yosemite hantavirus outbreak on hantavirus antibody testing at a national reference laboratory. Clin Vaccine Immunol. 2013 Aug;20(8):1213\u20136.","DOI":"10.1128\/CVI.00326-13"},{"key":"2022091918191493589_j_med-2021-0336_ref_027","unstructured":"Centers for Disease C, Prevention. False-positive results with a commercially available West Nile virus immunoglobulin m assay \u2013 United States, 2008. Morb Mortal Wkly Rep. 2009 May 8;58(17):458\u201360."},{"key":"2022091918191493589_j_med-2021-0336_ref_028","doi-asserted-by":"crossref","unstructured":"Seriburi V\n, \nNdukwe N\n, \nChang Z\n, \nCox ME\n, \nWormser GP\n. High frequency of false positive IgM immunoblots for Borrelia burgdorferi in clinical practice. Clin Microbiol Infect. 2012 Dec;18(12):1236\u201340.","DOI":"10.1111\/j.1469-0691.2011.03749.x"},{"key":"2022091918191493589_j_med-2021-0336_ref_029","doi-asserted-by":"crossref","unstructured":"Valota M\n, \nThienemann F\n, \nMisselwitz B\n. False-positive serologies for acute hepatitis A and autoimmune hepatitis in a patient with acute Epstein-Barr virus infection. BMJ Case Rep. 2019 May 10;12:5.","DOI":"10.1136\/bcr-2018-228356"},{"key":"2022091918191493589_j_med-2021-0336_ref_030","doi-asserted-by":"crossref","unstructured":"Landry ML\n. Immunoglobulin M for Acute Infection: True or False. Clin Vaccine Immunol. 2016 Jul;23(7):540\u20135.","DOI":"10.1128\/CVI.00211-16"},{"key":"2022091918191493589_j_med-2021-0336_ref_031","doi-asserted-by":"crossref","unstructured":"Jenkerson SA\n, \nBeller M\n, \nMiddaugh JP\n, \nErdman DD\n. False positive rubeola IgM tests. N Engl J Med. 1995 Apr 20;332(16):1103\u20134.","DOI":"10.1056\/NEJM199504203321616"},{"key":"2022091918191493589_j_med-2021-0336_ref_032","doi-asserted-by":"crossref","unstructured":"Costa E\n, \nTormo N\n, \nClari MA\n, \nBravo D\n, \nMunoz-Cobo B\n, \nNavarro D\n. Performance of the Epstein-Barr virus and herpes simplex virus immunoglobulin m assays on the liaison platform with sera from patients displaying acute parvovirus B19 infection. Clin Vaccine Immunol. 2009 Aug;16(8):1247\u20138.","DOI":"10.1128\/CVI.00142-09"},{"key":"2022091918191493589_j_med-2021-0336_ref_033","doi-asserted-by":"crossref","unstructured":"Lanciotti RS\n, \nKerst AJ\n, \nNasci RS\n, \nGodsey MS\n, \nMitchell CJ\n, \nSavage HM\n, et al. Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol. 2000 Nov;38(11):4066\u201371.","DOI":"10.1128\/JCM.38.11.4066-4071.2000"},{"key":"2022091918191493589_j_med-2021-0336_ref_034","doi-asserted-by":"crossref","unstructured":"Jang JH\n, \nJung YM\n, \nKim JS\n, \nLee SH\n, \nKim JW\n, \nHwang SG\n, et al. Coexistence of IgM antihepatitis A virus and IgM antihepatitis E virus in acute viral hepatitis: a prospective, multicentre study in Korea. J Viral Hepat. 2011 Oct;18(10):e408\u201314.","DOI":"10.1111\/j.1365-2893.2011.01477.x"},{"key":"2022091918191493589_j_med-2021-0336_ref_035","doi-asserted-by":"crossref","unstructured":"Ritter S\n, \nSchroder S\n, \nUy A\n, \nRitter K\n. Haemolysis in hepatitis A virus infections coinciding with the occurrence of autoantibodies against triosephosphate isomerase and the reactivation of latent persistent Epstein-Barr virus infection. J Med Virol. 1996 Nov;50(3):272\u20135.","DOI":"10.1002\/(SICI)1096-9071(199611)50:3<272::AID-JMV10>3.0.CO;2-M"},{"key":"2022091918191493589_j_med-2021-0336_ref_036","doi-asserted-by":"crossref","unstructured":"Hassan A\n, \nFontana RJ\n. The diagnosis and management of idiosyncratic drug-induced liver injury. Liver Int. 2019 Jan;39(1):31\u201341.","DOI":"10.1111\/liv.13931"},{"key":"2022091918191493589_j_med-2021-0336_ref_037","doi-asserted-by":"crossref","unstructured":"Katarey D\n, \nVerma S\n. Drug-induced liver injury. Clin Med (Lond). 2016 Dec;16(Suppl 6):s104\u20139.","DOI":"10.7861\/clinmedicine.16-6-s104"},{"key":"2022091918191493589_j_med-2021-0336_ref_038","doi-asserted-by":"crossref","unstructured":"Zhu P\n, \nLi J\n, \nFu X\n, \nYu Z\n. Schisandra fruits for the management of drug-induced liver injury in China: a review. Phytomedicine. 2019 Jun;59:152760.","DOI":"10.1016\/j.phymed.2018.11.020"},{"key":"2022091918191493589_j_med-2021-0336_ref_039","doi-asserted-by":"crossref","unstructured":"Li Z\n, \nHe X\n, \nLiu F\n, \nWang J\n, \nFeng J\n. A review of polysaccharides from Schisandra chinensis and Schisandra sphenanthera: Properties, functions and applications. Carbohydr Polym. 2018 Mar 15;184:178\u201390.","DOI":"10.1016\/j.carbpol.2017.12.058"}],"container-title":["Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2021-0336\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2021-0336\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T14:30:55Z","timestamp":1663597855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2021-0336\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,7,15]]},"published-print":{"date-parts":[[2021,7,15]]}},"alternative-id":["10.1515\/med-2021-0336"],"URL":"https:\/\/doi.org\/10.1515\/med-2021-0336","relation":{},"ISSN":["2391-5463"],"issn-type":[{"value":"2391-5463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,1]]}}}